article thumbnail

Drug development trends: insight from Thermo Fisher’s Anil Kane

European Pharmaceutical Review

They could be for the oncology space, including different types of cancers, central nervous system indications such as Alzheimer’s, Parkinson’s and epilepsies, and also the most common indications for diabetes and other metabolic disorders. Also, we can expect to see the utilisation of digital technologies for predictive modelling.

article thumbnail

Pharma News: Latest Trends and Insights for Marketing Teams

Pharma Marketing Network

For example, targeting oncologists for a drug like Opdivo requires a unique approach compared to marketing a diabetes treatment. Technologies like AI, big data, and AR/VR streamline processes, improve targeting, and create more engaging campaigns. How can technology enhance pharma marketing strategies?

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NHC Submits Comments on CMS Draft Guidance for IPAY 2028

Putting Patients First Blog

24 To ensure that listening sessions yield actionable, patient-centered insights, the NHC recommends the following process improvements focused on accessibility, clarity, and broad participation of stakeholders: CMS should provide a minimum of 30 days’ advance notice and allow scheduling flexibility for all listening sessions.

article thumbnail

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

It is caused by the natural aging process and can be a risk for people who have diabetes, are obese, perform little to no exercise, have a poor nutrition, or smoke. To ensure an efficient process, MyMD works closely with the contract manufacturing organisation (CMO) focusing on automation and process improvement.